Xeris Pharmaceuticals XERS 深 沪
已收盘 09-20 16:00:00 美东时间
2.93
-0.030
-1.01%
华盛通- 最 高2.97
- 今 开2.96
- 成交量 194.12万股
- 最 低 2.89
- 昨 收 2.96
- 总市值 4.04亿
- 52周最高 3.26
- 市盈率 静 --
- 换手率 1.41%
- 52周最低 1.46
- 委 比 -65.68%
- 总股本 1.38亿
- 历史最高 27.983
- 量 比 0.95
- 振 幅 2.70%
- 历史最低 0.9701
- 每 手 1
- 风险率 0.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Reiterates Buy on Xeris Biopharma Holdings, Maintains $6 Price Target
HC Wainwright & Co. analyst Oren Livnat reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and maintains $6 price target.
08-15 18:14
Oppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS)
Oppenheimer analyst Leland Gershell maintained a Buy rating on Xeris Pharmaceut...
08-12 19:59
Xeris Biopharma Holdings Q2 2024 GAAP EPS $(0.10) Beats $(0.11) Estimate, Sales $46.512M Beat $45.811M Estimate
Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. The company reported quarterly sales of $46.512 million which
08-08 19:02
Xeris Pharmaceuticals Appoints Kevin McCulloch as President and COO
Xeris Pharmaceuticals (XERS) just unveiled an announcement. Xeris Biopharma Hol...
08-03 04:32
新浪财经ESG：Xeris Pharmaceuticals Inc 路孚特（Refinitiv）ESG评级调升至C-
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-30 07:04
When Will Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Breakeven?
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) is possibly approaching a major ac...
07-17 03:40
Xeris Pharmaceuticals Undergoes Executive Leadership Transition
The latest update is out from Xeris Pharmaceuticals (XERS). Paul R. Edick is st...
07-08 19:47
Xeris Biopharma CEO Paul Edick to retire
Xeris Biopharma (NASDAQ:XERS) said Paul Edick will be retiring from his day-to-day operational and chairman role after more than seven years with the company. The firm has appointed COO, John Shannon,...
07-08 19:31
Xeris Pharmaceuticals Shareholders Back Key Proposals and Directors
Xeris Pharmaceuticals (XERS) has provided an announcement. During Xeris Biophar...
06-06 05:03
成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间02:32（距离美股收盘不到90分钟）该公司宣布Harmoni-2第三阶段临床试验结果实现主要终点其控制特定类型肺癌的效果超越默克制药的Keytruda。Humacyte涨18.03%Xeris Pharmaceuticals涨15.03%AC Immune涨8.17%Sarepta...
成分股Summit Therapeutics Plc.收涨272.06%领跑使得最近六个月累计涨幅达到412.68%其竞争对手默克制药则收跌1.09%；北京时间...
05-31 05:57
